Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2014 Jan;76(1):29-37.
doi: 10.1097/PSY.0000000000000022. Epub 2013 Dec 23.

Effect of collaborative care for depression on risk of cardiovascular events: data from the IMPACT randomized controlled trial

Jesse C Stewart  1 , Anthony J Perkins, Christopher M Callahan
Affiliations
Randomized Controlled Trial

Effect of collaborative care for depression on risk of cardiovascular events: data from the IMPACT randomized controlled trial

Jesse C Stewart et al. Psychosom Med. 2014 Jan.

Abstract

Objective: Although depression is a risk and prognostic factor for cardiovascular disease (CVD), depression trials involving cardiac patients have not observed the anticipated cardiovascular benefits. To test our hypothesis that depression treatment delivered before clinical CVD onset reduces risk of CVD events, we conducted an 8-year follow-up study of the Indiana sites of the Improving Mood-Promoting Access to Collaborative Treatment (IMPACT) randomized controlled trial.

Methods: Participants were 235 primary care patients 60 years or older with major depression or dysthymia who were randomized to a 12-month collaborative care program involving antidepressants and psychotherapy (85 without and 35 with baseline CVD) or usual care (83 without and 32 with baseline CVD). Hard CVD events (fatal/nonfatal) were identified using electronic medical record and Medicare/Medicaid data.

Results: A total of 119 patients (51%) had a hard CVD event. As hypothesized, the treatment × baseline CVD interaction was significant (p = .021). IMPACT patients without baseline CVD had a 48% lower risk of an event than did usual care patients (28% versus 47%, hazard ratio = 0.52, 95% confidence interval = 0.31-0.86). The number needed to treat to prevent one event for 5 years was 6.1. The likelihood of an event did not differ between IMPACT and usual care patients with baseline CVD (86% versus 81%, hazard ratio = 1.19, 95% confidence interval, 0.70-2.03).

Conclusions: Collaborative depression care delivered before CVD onset halved the excess risk of hard CVD events among older, depressed patients. Our findings raise the possibility that the IMPACT intervention could be used as a CVD primary prevention strategy.

Trial registration: clinicaltrials.gov Identifier: NCT01561105.

Keywords: cerebrovascular disorders; coronary disease; depression; follow-up studies; prevention.

PubMed Disclaimer

Conflict of interest statement

Potential Conflicts of Interest

None.

Figures

Figure 1
Figure 1
Flowchart of participants from the Indiana sites of the Improving Mood-Promoting Access to Collaborative Treatment (IMPACT) Randomized Controlled Trial.
Figure 2
Figure 2
Kaplan-Meier survival curves for time to (A) hard CVD events, (B) fatal or nonfatal MI, (C) fatal or nonfatal stroke, and (D) all-cause mortality. CVD = cardiovascular disease. MI = myocardial infarction. IMPACT = Improving Mood-Promoting Access to Collaborative Treatment.
See this image and copyright information in PMC

References

    1. Van der Kooy K, van Hout H, Marwijk H, Marten H, Stehouwer C, Beekman A. Depression and the risk for cardiovascular diseases: systematic review and meta analysis. Int J of Geriatr Psychiatry. 2007;22:613–26. - PubMed
    1. Meijer A, Conradi HJ, Bos EH, Thombs BD, van Melle JP, de Jonge P. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. Gen Hosp Psychiatry. 2011;33:203–16. - PubMed
    1. Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ, Czajkowski SM, DeBusk R, Hosking J, Jaffe A, Kaufmann PG, Mitchell P, Norman J, Powell LH, Raczynski JM, Schneiderman N. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA. 2003;289:3106–16. - PubMed
    1. Davidson KW, Rieckmann N, Clemow L, Schwartz JE, Shimbo D, Medina V, Albanese G, Kronish I, Hegel M, Burg MM. Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial. Arch of Intern Med. 2010;170:600–8. - PMC - PubMed
    1. Glassman AH, O’Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT, Jr, Krishnan KR, van Zyl LT, Swenson JR, Finkel MS, Landau C, Shapiro PA, Pepine CJ, Mardekian J, Harrison WM, Barton D, McLvor M Sertraline Antidepressant Heart Attack Randomized Trial Group. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002;288:701–9. - PubMed

Publication types

MeSH terms

Substances

Associated data